© 2020 Ncardia

close
  Search
x

Ncardia provides a broad menu of Drug Safety and Toxicity services including custom assay development

Cardiovascular Safety & Toxicity Evaluation Services

Assessment of drug safety and toxicity is complex and can be time consuming. Cardiac toxicity may be observed after short or long-term compound exposure. Additionally, structural and functional aspects of cardiac toxicity need to be considered. Uncovering potential cardiotoxic effects of drug candidates earlier in the drug discovery process will decrease drug attrition rates and saves needed resources. Ncardia provides integrated cardiovascular services to enhance the assessment of cardiac safety and toxicity of drug candidates. All services utilize functional human iPSC-derived cell models in qualified assays.

Benefits of Ncardia Safety Services:

Quality - Domain experts, qualified cells & platforms

Time savings - Assays and analysis performed for you

Customization - Menu of assays & technologies

Full service - Dedicated team to meet your needs

 

Request a quote

Safety Services

 

Ncardia provides a broad menu of services utilizing a variety of cell models, including endothelial, smooth muscle and neural cells. We also routinely perform biochemical characterization of client models.

Schedule a consultation with our safety services experts to discuss customized services for your specific needs.

 

Connect with us to discuss your project

MEA

Acute Cardiac Safety - MEA Analysis

Provides an acute cardiac safety profile of your compound based on current CiPA initiative protocols for microelectrode arrays (MEA) analysis.

EBT

Endothelial Barrier Toxicity

Assessment of drug-induced vascular leakage using high-content, real-time and label-free impedance-based technology that monitors changes in electrical impedance across the endothelial cell monolayer.

CF

Calcium Transients

High-throughput screening of compound effects on cardiomyocyte electrophysiology by analyzing the intracellular calcium transients.

I

Acute & Chronic Cytotoxicity - Impedance Analysis

Provides an acute and long-term cardiac safety profile based on label-free impedance analysis of your compounds using hiPSC-derived cardiomyocytes.

CT

Structural Toxicity - Troponin Detection

Delivers a structural cardiotoxicity profile of your compounds based on the detection of cardiac specific biomarkers like Troponin I release by hiPSC-derived cardiomyocytes.

 

MP

Multiplexed Functional & Structural Cardiotoxicity

An analysis by impedance (contractility), electrophysiology and biomarker release (structural).

CPS

Customized Project Service

Get in contact with us to discuss a custom assay development project. Ncardia has a menu of qualified human iPSC-derived cell models, technology platforms and domain experts to develop and execute an assay that is build to your specifications.

Safety Evaluation Services

 

Please subscribe to our Newsletter

Cookie notice

The Ncardia website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping us to understand which sections of the website you find most interesting and useful. Find out more at: Privacy Policy.


I accept cookies I refuse cookies